Are lipid ratios better indices for evaluating hyperlipidemia? A prospective observational study from a rural region of North Kerala
DOI:
https://doi.org/10.51248/.v43i02.2320Keywords:
Atherogenic coefficient, Castelli risk index, dyslipidemia, fatty liverAbstract
Introduction and Aim: Historically lipid profile has been used to evaluate hyperlipidemia. More recently lipid ratios have been used particularly in studies from the west. The aim of this study is to evaluate dyslipidemia using both the conventional lipid profile and lipid ratios and to assess its relationship with fatty liver disease.
Materials and Methods: Fasting lipid profile, lipid ratios such as the Castelli Risk Index-I (CR-I TC/HDL), Castelli Risk Index II (CR-II LDL/HDL), atherogenic coefficient (non-HDL/HDL) were assessed in our study population of 150 subjects. Any changes noted in serum lipids were correlated with ultrasonography of the liver.
Results: Significant changes in lipid ratios such as CR-II was noted in the age group 50-59 years and was statistically significant (p=0.053).CR-I, CR-II and AC indicated a cardiovascular risk prevalence of 22.6%,36.7% and 50.7% respectively. The two ratios which were significantly altered across the various subtypes of fatty liver were LDL/HDL(p=0.018) and non-HDL/HDL (p=0.00).
Conclusion: This study emphasizes the importance of lipid ratios in early screening.
References
Joshi, S.R., Anjana, R.M., Deepa, M., Pradeepa, R., Bhansali, A., Dhandania, V. K., et al., Prevalence of dyslipidaemia in Urban and Rural India. The ICMR-INDIAB Study. PLOS ONE 2014;9(5):e96808.
Aslesh, O.P., Jayasree, A.K., Usha, K., Venugopalan, A.K., Binoo, D., Mayamol, T.R., et al., Prevalence of hypercholesterolemia among adults aged over 30 years in a rural area of North Kerala, India: a cross-sectional study. WHO South-East Asia J Public Health 2016; 5;70-75.
Sadeghi, M., Roohafza, H., Serum lipid distribution and prevalence of dyslipidaemia in Urban and rural communities in Iran -IHHP study. IHPP Abstracts 2005 Isfahan Healthy Heart Program: A Comprehensive Integrated Community-based Program for Cardiovascular Disease Prevention and Control. Acta Cardiologica. 2003; 58(4).
Olamoyegun, M.A., Oluyombo, R., Asaolu, S.O., Evaluation of dyslipidaemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria. Annals of African Medicine. 2016;15(4): 194-199.
Pereira, T., Dyslipidaemia -From Prevention to Treatment: Intechopen.com;2012
Bergmann, K., Non-HDL cholesterol and Evaluation of Cardiovascular disease risk. The journal of the International Federation of Clinical Chemistry and Laboratory Medicine. 2010;21(3);64-67.
Amor, A.J., Perea, V., Dyslipidaemia in non-alcoholic fatty liver disease. Curr Opin Endocrinol Diabetes Obes. 2019; 26:103-108.
Charles, C.A., Lucy, S. P., Cicely, S.G.C., Richmond, W., Paul, C. F., Clinical Chemistry, Oxford Academic.
Trinder, P. Enzymatic Colorimetric Determination of Triglycerides by GPO-PAP Method. Annals of Clinical Biochemistry. 1969; 6: 24-27.
Naito, H.K.HDL Cholesterol. Kaplan A., Clin Chem. The C.V. Mosby Co., St Louis, Toronto, Princeton, 1984; 437: 1207-1213.
Friedwald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge, Clin.Chem.1972;18:499-502.
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486 -2497.
Aggarwal, J., Reddy, S., Nagtilak, S., Evaluation of Non-HDL-Cholesterol/HDL –Cholesterol ratio as a predictor of coronary artery disease. International Journal of Advanced Research. 2014; 2(5): 277-283.
Harmeet, K., Aeri, B.T., Assessing the prevalence of Dyslipidaemia in Apparently Healthy Urban Obese Adults residing in South Delhi, India.J. Gizi Pangan .2020;15(2):63-70.
Chandra, K.S., Bansal, M.M., Nair, T., Iyengar, S.S., Gupta, R., Subhash, C., et al., Consensus statement on management of dyslipidaemia in Indian subjects. Indian Heart Journal.2014; 66 (3): S1-S51.
Wankhede, P.S., Pedhambkar, R.B., Pedhambkar, B.S., Prevalence, and risk factors of dyslipidaemia among male industrial workers in India. International Journal of Community Medicine and Public Health 2018; 5(4):1458-1465.
Bril, F., Lomonaco, R., and Cusi, K., The challenge of managing dyslipidaemia in patients with non-alcoholic fatty liver disease. Clinical Lipidology 2012;7(4): 471-481.
Cohen, D.E., and Fisher, E.A., Lipoprotein metabolism, Dyslipidaemia and Non-alcoholic fatty liver disease. Semin Liver Dis 2013 ;33(4): 380-388.
Wang, K., Shan, S., Zheng, H., Zao, H., Chen, C., and Liu, C., Non-HDL cholesterol to HDL- Cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL Cholesterol: a Cohort Study. Lipids Health Dis 2018; 17(1) :196.
Aggarwal, J., Kathariya, G., Verma, P.K., LDL-C, Non-HDL-C and Apo-B for cardiovascular risk assessment: looking for the ideal marker. Indian Heart Journal. 2021; 73:544-548.
Nimmanapalli, H.D., Kasi, A.D., Devapatla, P.K., Vani, N., Lipid ratios, atherogenic coefficient and atherogenic index of plasma as parameters in assessing cardiovascular risk in type 2 diabetes mellitus. Int J Res Med Sci .2016;4(7):2863-2869.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Biomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Plum Analytics